Teladoc Health TDOC Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.3%-0.2pp | 69.5%-0.3pp | 69.8%-0.5pp | 70.3%-0.2pp | 70.5%-0.3pp | |
| Operating margin | -8.1%+2.3pp | -10.4%+0.5pp | -10.9%-0.4pp | -10.5%+30.8pp | -41.3%-1.6pp | |
| Net margin | -6.8%+1.1pp | -7.9%+0.9pp | -8.8%-0.7pp | -8.2%+31.5pp | -39.7%-0.7pp | |
| EBITDA margin | 6.1%+2.6pp | 3.5%+0.7pp | 2.8%-0.3pp | 3.1%+30.6pp | -27.5%-1.9pp | |
| Free cash flow margin | 11.1%-0.1pp | 11.3%+0.2pp | 11.1%-0.4pp | 11.5%+0.2pp | 11.3%+0.3pp | |
| Returns | ||||||
| Return on equity | -12.4%+1.5pp | -13.9%+1.5pp | -15.4%-1.2pp | -14.2%+40.3pp | -54.5%-2.0pp | |
| Return on assets | -5.5%+0.8pp | -6.3%+0.7pp | -7%-0.5pp | -6.5%+19.6pp | -26.1%-0.8pp | |
| Return on invested capital | -28%+8.6pp | -36.6%-1.7pp | -34.9%-3.9pp | -31.1%+70.8pp | -101.9%-1.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×+0.1× | 0.7×0.0× | |
| Inventory turnover | 22.2×+2.0× | 20.2×+0.4× | 19.9×-0.8× | 20.7×-0.7× | 21.4×-0.8× | |
| Liquidity | ||||||
| Current ratio | 2.8×0.0× | 2.8×+0.1× | 2.7×0.0× | 2.7×+1.0× | 1.7×-0.1× | |
| Quick ratio | 2.7×0.0× | 2.7×+0.1× | 2.6×0.0× | 2.6×+0.9× | 1.6×-0.1× | |
| Cash ratio | 1.9×-0.1× | 1.9×+0.1× | 1.8×+0.1× | 1.7×+0.4× | 1.3×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×-0.4× | 0.4×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×-0.2× | 0.2×0.0× | |
| Net debt / EBITDA | -4.7×— | —— | —— | —— | —— | |
| Interest coverage | -10.6×+2.8× | -13.3×-0.6× | -12.7×-1.0× | -11.8×+32.3× | -44.1×-1.2× | |
| Per Share | ||||||
| Book value per share | $7.46-5.1% | $7.86-0.1% | $7.87-2.7% | $8.08-1.3% | $8.19-6.3% | |
| Valuation | ||||||
| Market capitalization | $1.43B+18.0% | $1.24B-9.0% | $1.37B-2.7% | $1.4B+1.5% | $1.38B-11.7% | |
| Enterprise value | $719.36M+17.6% | $506.47M-26.3% | $687.6M-10.2% | $765.78M-2.3% | $783.58M-8.9% | |
| Price / sales | 0.6×+0.1× | 0.5×0.0× | 0.5×0.0× | 0.6×0.0× | 0.5×-0.1× | |
| Price / book | 1.1×+0.2× | 0.9×-0.1× | 1×0.0× | 1×0.0× | 1×-0.1× | |
| EV / EBITDA | 4.7×— | —— | —— | —— | —— | |
| EV / sales | 0.3×0.0× | 0.2×-0.1× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Free cash flow yield | 19.6%-4.2pp | 23%+2.5pp | 20.5%-0.3pp | 20.8%-0.1pp | 20.9%+2.8pp | |
| Earnings yield | -12%+71.6pp | -16.1%+0.2pp | -16.4%-1.6pp | -14.8%+58.5pp | -73.2%-9.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Teladoc Health's profit margins?
- Teladoc Health (TDOC) runs a 69.3% gross margin and a -8.1% operating margin, with a -6.8% net margin.
- Where do Teladoc Health's ratios come from?
- Every ratio is computed from Teladoc Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
